Patient Experience Sheds Light on Complexities of Antithrombotic Care in APS – APS Foundation of America
APS Foundation of America shared a post on LinkedIn:
“Malpas woman fears treatment after Cheshire hospital ordeal.
A woman from Malpas has said her health has been severely damaged after she was treated with excessive amounts of blood thinners following a heart attack.
Claire Howell was rushed to Leighton Hospital near Crewe on March 22, where she received treatment for a heart attack.
Ms Howell, who suffers from antiphospholipid syndrome (APS) – a condition which causes the blood to be thicker and more prone to clotting, was placed on a range of blood-thinning medication.
This included clopidogrel, aspirin, and injections of tinzaparin – Ms Howell says that the volume of medication was excessive and adds that on one occasion a nurse attempted ‘to give me the same medication twice’.
‘I was being given three lots of blood thinners every day,’ Claire said.
‘I couldn’t eat a thing while in hospital, and I was losing weight at a rapid pace.’
The blood thinners meant that Claire was experiencing consistent nausea, her vomit contained large amounts of blood, so much so Claire said it was ‘black’, together with light-headedness and blood in her stool.
Claire’s symptoms were consistent with gastrointestinal bleeding, and this severely affected her ability to digest food and maintain her weight.
Ms. Howell said she had weighed around 56 kilogram when she was admitted and had lost more than 15 kilogram.
Read more.”
Stay updated with Hemostasis Today.
-
Jun 21, 2026, 08:04Phil Ambery: Next-Generation Endothelin Therapeutics Renew Interest in a Proven Pathway
-
Jun 21, 2026, 07:50Pallavi Madhiraju: Evategrel Shows Promise for Rapid and Consistent Platelet Inhibition
-
Jun 21, 2026, 07:39Heghine Khachatryan: Emerging Evidence Links NET Formation to Thrombosis and Disease Progression in Gynecologic Malignancies
-
Jun 21, 2026, 07:24Seema Dawood: The Power of Blood Smear Confirmation in Detecting Immature Granulocytes
-
Jun 21, 2026, 05:32Flora Peyvandi: Characterizing Acquired VWD Through a Large Patient Cohort
-
Jun 21, 2026, 05:23Mohammed Alo: The Gap Between Nattokinase Marketing and Evidence
-
Jun 21, 2026, 05:11Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar N63
-
Jun 21, 2026, 04:00X. Long Zheng: New Findings on ADAMTS13 in Hemostasis and Thrombosis
-
Jun 21, 2026, 03:04Mauricio Vasco Ramirez: Balancing Bleeding and Thrombotic Risks in Ultrasound-Guided Intervention